-
3
-
-
0034760435
-
Analysis of common side effects of isotretinoin
-
DOI 10.1067/mjd.2001.113719
-
McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001 ; 45: S188 - S194. (Pubitemid 33032599)
-
(2001)
Journal of the American Academy of Dermatology
, vol.45
, Issue.5
-
-
McLane, J.1
-
6
-
-
2142712507
-
A review of systemic retinoid therapy for acne and related conditions
-
Kunynetz RA A review of systemic retinoid therapy for acne and related conditions. Skin Therapy Lett. 2004 ; 9: 1-4.
-
(2004)
Skin Therapy Lett
, vol.9
, pp. 1-4
-
-
Kunynetz, R.A.1
-
7
-
-
0023905450
-
Adverse reactions to isotretinoin: A report from the Adverse Drug Reaction Reporting System
-
Bigby M., Stern R. Adverse reactions to isotretinoin: a report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol. 1998 ; 18: 543-552.
-
(1998)
J Am Acad Dermatol
, vol.18
, pp. 543-552
-
-
Bigby, M.1
Stern, R.2
-
9
-
-
0023138551
-
Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin
-
Vahlquist C., Lithell H., Michaelsson G., Selinus I., Vahlquist A., Vessby B. Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin. Acta Derm Venereol. 1987 ; 67: 139-144. (Pubitemid 17032845)
-
(1987)
Acta Dermato-Venereologica
, vol.67
, Issue.2
, pp. 139-144
-
-
Vahlquist, C.1
Lithell, H.2
Michaelsson, G.3
-
10
-
-
0021972335
-
A sequential comparison of etretinate (Tigason®) and isotretinoin (Roaccutane®) with special regard to their effects on serum lipoproteins
-
DOI 10.1111/j.1365-2133.1985.tb02293.x
-
Valhquist C., Michaelsoon G., Valhquist A., Vessy B. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins. Br J Dermatol. 1985 ; 112: 69-76. (Pubitemid 15198180)
-
(1985)
British Journal of Dermatology
, vol.112
, Issue.1
, pp. 69-76
-
-
Vahlquist, C.1
Michaelsson, G.2
Vahlquist, A.3
Vessby, B.4
-
11
-
-
0032145190
-
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor: Contribution to the hypertriglyceridemic action of retinoids
-
Vu-Dac N., Gervois P., Torra IP, et al. Retinoids increase human apo C-III expression at the transcriptional level via retinoid X receptor: contribution to the hypertriglyceridemic action of retinoids. J Clin Invest. 1998 ; 102: 625-632. (Pubitemid 28376165)
-
(1998)
Journal of Clinical Investigation
, vol.102
, Issue.3
, pp. 625-632
-
-
Vu-Dac, N.1
Gervois, P.2
Torra, I.P.3
Fruchart, J.-C.4
Kosykh, V.5
Kooistra, T.6
Princen, H.M.G.7
Dallongeville, J.8
Staels, B.9
-
12
-
-
33344459633
-
Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne
-
DOI 10.1007/s00403-006-0638-4
-
De Marchi MA, Maranhao RC, Brandizzi LI, Souza DR Effects of isotretinoin on the metabolism of triglycerides and on the lipid profile in patients with acne. Arch Dermatol Res. 2006 ; 297: 403-408. (Pubitemid 43288215)
-
(2006)
Archives of Dermatological Research
, vol.297
, Issue.9
, pp. 403-408
-
-
De Marchi, M.A.1
Maranhao, R.C.2
Brandizzi, L.I.V.3
Souza, D.R.S.4
-
13
-
-
0027473730
-
Effects of retinoic acid on lipoprotein lipase activity and mRNA level in vitro and in vivo
-
DOI 10.1016/0006-2952(93)90130-O
-
Oliver JD, Rogers MP Effects of retinoic acid on lipoprotein lipase activity and mRNA level in vitro and in vivo. Biochem Pharmacol. 1993 ; 45: 579-583. (Pubitemid 23064562)
-
(1993)
Biochemical Pharmacology
, vol.45
, Issue.3
, pp. 579-583
-
-
Oliver, J.D.1
Rogers, M.P.2
-
14
-
-
9344235448
-
Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening
-
Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol. 1996 ; 36: 604-609. (Pubitemid 26260540)
-
(1996)
Journal of Clinical Pharmacology
, vol.36
, Issue.7
, pp. 604-609
-
-
Cilla Jr., D.D.1
Gibson, D.M.2
Whitfield, L.R.3
Sedman, A.J.4
-
15
-
-
33748042671
-
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
-
DOI 10.1016/j.pharmthera.2006.03.003, PII S0163725806000404
-
Shitara Y., Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006 ; 112: 71-105. (Pubitemid 44301483)
-
(2006)
Pharmacology and Therapeutics
, vol.112
, Issue.1
, pp. 71-105
-
-
Shitara, Y.1
Sugiyama, Y.2
-
16
-
-
9044230921
-
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
-
DOI 10.1001/jama.275.2.128
-
Bakker-Arkema RG, Davidson MH, Goldstein RJ, et al. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA. 1996 ; 275: 128-133. (Pubitemid 26022591)
-
(1996)
Journal of the American Medical Association
, vol.275
, Issue.2
, pp. 128-133
-
-
Bakker-Arkema, R.G.1
Davidson, M.H.2
Goldstein, R.J.3
Davignon, J.4
Isaacsohn, J.L.5
Weiss, S.R.6
Keilson, L.M.7
Brown, W.V.8
Miller, V.T.9
Shurzinske, L.J.10
Black, D.M.11
-
17
-
-
33748767904
-
An adolescent with abdominal pain taking isotretinoin for severe acne
-
DOI 10.1097/01.smj.0000223658.00852.d8, PII 0000761120060900000021
-
Greene JP An adolescent with abdominal pain taking isotretinoin for severe acne. South Med J. 2006 ; 99: 992-994. (Pubitemid 44408846)
-
(2006)
Southern Medical Journal
, vol.99
, Issue.9
, pp. 992-994
-
-
Greene, J.P.1
|